Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 32-42 , March 2007

Poly(ethylene glycol)–modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery

  • Sushma Kommareddy, PhD
  • ,
  • Mansoor Amiji, BS, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115.

Received 4 October 2006 ,Accepted 22 November 2006.

References 

  1. Labhasetwar V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Curr Opin Biotechnol. 2005;16(6):674–680
  2. Read ML, Logan A, Seymour LW. Barriers to gene delivery using synthetic vectors. Adv Genet. 2005;53:19–46
  3. Lehrman S. Virus treatment questioned after gene therapy death. Nature. 1999;401(6753):517–518
  4. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 2003;299(5605):320
  5. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4(5):346–358
  6. Blessing T, Remy JS, Behr JP. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A. 1998;95(4):1427–1431
  7. Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol Ther. 2000;2(4):302–317
  8. Naper DH. Polymeric stabilization of colloidal dispersions. New York: Academic Press; 1983;
  9. Kommareddy S, Tiwari SB, Amiji MM. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat. 2005;4(6):615–626
  10. Kaul G, Amiji M. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target. 2004;12(9-10):585–591
  11. Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res. 2005;22(6):951–961
  12. Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharm Sci. 2006;Published online
  13. Kommareddy S, Amiji M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug Chem. 2005;16(6):1423–1432
  14. Snyder SL, Sobocinski PZ. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem. 1975;64(1):284–288
  15. Size A, Erickson D, Ren L, Li D. Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. J Colloid Interface Sci. 2003;261:402–410
  16. Sherwood MA. Data analysis in X-ray photoelectron spectroscopy. In:  Briggs D,  Seah MP editor. Practical surface analysis. Vol. 2:New York: John Wiley; 1990;p. 555–586
  17. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 1994;54(13):3352–3356
  18. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 1994;54(17):4564–4568
  19. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. 1990;50(3 Suppl):814s–819s
  20. Jang SH, Wientjes MG, Lu D, Au JL. Drug delivery and transport to solid tumors. Pharm Res. 2003;20(9):1337–1350
  21. Kaul G, Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res. 2002;19(7):1062–1068
  22. Kaul G, Amiji M. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J Pharm Sci. 2004;94(1):184–198

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(06)00339-X

doi: 10.1016/j.nano.2006.11.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 1 , Pages 32-42 , March 2007